메뉴 건너뛰기
American Journal of Kidney Diseases
Volumn 61, Issue 5, 2013, Pages 710-715
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis with poor kidney function: A subgroup analysis of the aspreva lupus management study
Author keywords

acute kidney injury; chronic kidney disease; cyclophosphamide; Lupus nephritis; mycophenolate mofetil; randomized controlled trial
Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;
EID: 84876286366     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.11.042     Document Type: Article
Times cited : (54)
References (15)
  • 1
    • 65649140169 scopus 로고    scopus 로고
    • Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
    • G.B. Appel, G. Contreras, M.A. Dooley Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis J Am Soc Nephrol 20 5 2009 1103 1112
    • (2009) J Am Soc Nephrol , vol.20 , Issue.5 , pp. 1103-1112
    • Appel, G.B.1    Contreras, G.2    Dooley, M.A.3
  • 2
    • 37849051924 scopus 로고    scopus 로고
    • Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: Rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS)
    • A. Sinclair, G. Appel, M.A. Dooley Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS) Lupus 16 12 2007 972 980
    • (2007) Lupus , vol.16 , Issue.12 , pp. 972-980
    • Sinclair, A.1    Appel, G.2    Dooley, M.A.3
  • 3
    • 1642480050 scopus 로고    scopus 로고
    • The classification of glomerulonephritis in systemic lupus erythematosus revisited
    • J.J. Weening, D. D'Agati, M.M. Schwartz The classification of glomerulonephritis in systemic lupus erythematosus revisited Kidney Int 65 2 2004 521 530
    • (2004) Kidney Int , vol.65 , Issue.2 , pp. 521-530
    • Weening, J.J.1    D'Agati, D.2    Schwartz, M.M.3
  • 4
    • 0942265440 scopus 로고    scopus 로고
    • The classification of glomerulonephritis in systemic lupus erythematosus revisited
    • J.J. Weening, V.D. D'Agati, M.M. Schwartz The classification of glomerulonephritis in systemic lupus erythematosus revisited J Am Soc Nephrol 15 2 2004 241 250
    • (2004) J Am Soc Nephrol , vol.15 , Issue.2 , pp. 241-250
    • Weening, J.J.1    D'Agati, V.D.2    Schwartz, M.M.3
  • 5
    • 0001106451 scopus 로고    scopus 로고
    • A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]
    • A.S. Levey, T. Greene, J. Kusek, G. Beck A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract] J Am Soc Nephrol 11 2000 155A
    • (2000) J Am Soc Nephrol , vol.11
    • Levey, A.S.1    Greene, T.2    Kusek, J.3    Beck, G.4
  • 7
    • 73349129039 scopus 로고    scopus 로고
    • Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class v lupus nephritis
    • J. Radhakrishnan, D.A. Moutzouris, E.M. Ginzler, N. Solomons, I.I. Siempos, G.B. Appel Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis Kidney Int 77 2 2009 152 160
    • (2009) Kidney Int , vol.77 , Issue.2 , pp. 152-160
    • Radhakrishnan, J.1    Moutzouris, D.A.2    Ginzler, E.M.3    Solomons, N.4    Siempos, I.I.5    Appel, G.B.6
  • 8
    • 34548845067 scopus 로고    scopus 로고
    • Mycophenolate mofetil for induction therapy of lupus nephritis: A systematic review and meta-analysis
    • M. Walsh, M. James, D. Jayne, M. Tonelli, B.J. Manns, B.R. Hemmelgarn Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis Clin J Am Soc Nephrol 2 5 2007 968 975
    • (2007) Clin J Am Soc Nephrol , vol.2 , Issue.5 , pp. 968-975
    • Walsh, M.1    James, M.2    Jayne, D.3    Tonelli, M.4    Manns, B.J.5    Hemmelgarn, B.R.6
  • 9
    • 77349120902 scopus 로고    scopus 로고
    • Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study
    • D. Isenberg, G.B. Appel, G. Contreras Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study Rheumatology (Oxford) 49 1 2010 128 140
    • (2010) Rheumatology (Oxford) , vol.49 , Issue.1 , pp. 128-140
    • Isenberg, D.1    Appel, G.B.2    Contreras, G.3
  • 10
    • 78649751475 scopus 로고    scopus 로고
    • Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial
    • F.A. Houssiau, D. D'Cruz, S. Sangle Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial Ann Rheum Dis 69 12 2010 2083 2089
    • (2010) Ann Rheum Dis , vol.69 , Issue.12 , pp. 2083-2089
    • Houssiau, F.A.1    D'Cruz, D.2    Sangle, S.3
  • 11
    • 81455135753 scopus 로고    scopus 로고
    • Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
    • M.A. Dooley, D. Jayne, E.M. Ginzler Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis N Engl J Med 365 20 2011 1886 1895
    • (2011) N Engl J Med , vol.365 , Issue.20 , pp. 1886-1895
    • Dooley, M.A.1    Jayne, D.2    Ginzler, E.M.3
  • 12
    • 1442355581 scopus 로고    scopus 로고
    • Sequential therapies for proliferative lupus nephritis
    • G. Contreras, V. Pardo, B. LeClercq Sequential therapies for proliferative lupus nephritis N Engl J Med 350 10 2004 971 980
    • (2004) N Engl J Med , vol.350 , Issue.10 , pp. 971-980
    • Contreras, G.1    Pardo, V.2    Leclercq, B.3
  • 13
    • 34447529492 scopus 로고    scopus 로고
    • Surrogate end points in clinical trials: The case of anti-neutrophil cytoplasm antibody-associated vasculitis
    • M. Walsh, M. Tonelli, D. Jayne, B. Manns Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis J Nephrol 20 2 2007 119 129
    • (2007) J Nephrol , vol.20 , Issue.2 , pp. 119-129
    • Walsh, M.1    Tonelli, M.2    Jayne, D.3    Manns, B.4
  • 14
    • 77950224795 scopus 로고    scopus 로고
    • Practice pattern variation in oral glucocorticoid therapy after the induction of response in proliferative lupus nephritis
    • M. Walsh, D. Jayne, L. Moist, M. Tonelli, N. Pannu, B. Manns Practice pattern variation in oral glucocorticoid therapy after the induction of response in proliferative lupus nephritis Lupus 19 5 2010 628 633
    • (2010) Lupus , vol.19 , Issue.5 , pp. 628-633
    • Walsh, M.1    Jayne, D.2    Moist, L.3    Tonelli, M.4    Pannu, N.5    Manns, B.6
  • 15
    • 82955189288 scopus 로고    scopus 로고
    • Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis
    • M. Zeher, A. Doria, J. Lan Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis Lupus 20 14 2011 1484 1493
    • (2011) Lupus , vol.20 , Issue.14 , pp. 1484-1493
    • Zeher, M.1    Doria, A.2    Lan, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.